CERTIFAX
DEAD

Serial Number

75418920

Owner

BROWNOR ENTERPRISES, INC.

Attorney

C. Jeffrey Abbott

Filing Date

Jan 16, 1998

Add to watchlist:

No watchlists yet
View on USPTO

CERTIFAX Trademark

Serial Number: 75418920

CERTIFAX is a trademark filed by BROWNOR ENTERPRISES, INC. on January 16, 1998. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

BROWNOR ENTERPRISES, INC. (2 trademarks)

PO BOX 188
BEAVERTON, OR 97075

Entity Type: 03

Trademark Details

Filing Date

January 16, 1998

Registration Date

Not Registered

Published for Opposition

March 23, 1999

Goods & Services

Pharmacy goods, vitamins, and prescription medications, namely, corticosteroids, akalinkzing agents, aminoglycoside, antibiotics, amphetamines, anabolic steroids, androgfns, antacids, antimalarials, anticholinergics, anticholinesterases, anticoagulants, anticonvulsants, antidiarrheals, antihistamines, antipsoriatics, non-steroidal anti-inflammatory agents, antitubercular drugs, barbiturates, benzodiazephines, beta adrenergic blockers, bismuth salts, cholesterol lowering agents, calcium salts, cardiac glycosides, parasympathominetics, cephalosporins, cns depressants, cns stimulants, diuretics, potassium depleting, diuretics, potassium sparing, gallblader dyes, ergot alkaloids, estrogens, general anesthetics, antifungals, gypotensive agents, insulin preparations, iron prepartion, magnesium salts, mao inhibitors, muscle relaxants, progesterones, paba compounds, laxatives, penicillins, phenothiazines, potassium supplements, salicylates, sulfonamides, sulfonlureas, sympathominetic amines, tetracyclines, thiazides, thyroid preparations, tricyclic antidepressants, uricosuric agents, urinary acidifiers, vasodilators, peripheral, vasodilators, cardiac, vasopressors, xanthines, vitamin D preparations, propoxyphenes local anesthetics, emetics, antikparkinson agents, narcotic antagonists, codeine containing drugs, erythromycins, quindines, histamine-2 blockers, serums, antimanic agents, calcium channel-blocking agents, antiarrhythmics, penicillins/cephalosporing, nonsteriodal, anti-inflammatory agents/s, fluoroquinolones, cannabinoids, iodine-containing drugs, haemophilus B vaccines, adenosines, urinary anti-infectives, mao inhibitors, type B, alkylating agents, antimetabolites, antibiotics, antineoplastic and SSR inhibitors

Filing History

ABANDONMENT - NO USE STATEMENT FILED
Mar 19, 2000 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jun 15, 1999 NOAM
PUBLISHED FOR OPPOSITION
Mar 23, 1999 PUBO
NOTICE OF PUBLICATION
Feb 19, 1999 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 16, 1998 CNSA
EXAMINER'S AMENDMENT MAILED
Oct 6, 1998 CNEA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 28, 1998 CRFA
NON-FINAL ACTION MAILED
Jun 22, 1998 CNRT
ASSIGNED TO EXAMINER
Jun 10, 1998 DOCK